Long-distance charge transport in duplex DNA: the phonon-assisted polaron-like hopping mechanism PT Henderson, D Jones, G Hampikian, Y Kan, GB Schuster Proceedings of the National Academy of Sciences 96 (15), 8353-8358, 1999 | 719 | 1999 |
In vivo release from a drug delivery MEMS device Y Li, RS Shawgo, B Tyler, PT Henderson, JS Vogel, A Rosenberg, ... Journal of Controlled Release 100 (2), 211-219, 2004 | 298 | 2004 |
The hydantoin lesions formed from oxidation of 7, 8-dihydro-8-oxoguanine are potent sources of replication errors in vivo PT Henderson, JC Delaney, JG Muller, WL Neeley, SR Tannenbaum, ... Biochemistry 42 (31), 9257-9262, 2003 | 253 | 2003 |
The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma ME Smela, ML Hamm, PT Henderson, CM Harris, TM Harris, ... Proceedings of the National Academy of Sciences 99 (10), 6655-6660, 2002 | 252 | 2002 |
Oxidation of 7, 8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo PT Henderson, JC Delaney, F Gu, SR Tannenbaum, JM Essigmann Biochemistry 41 (3), 914-921, 2002 | 178 | 2002 |
Different apolipoproteins impact nanolipoprotein particle formation BA Chromy, E Arroyo, CD Blanchette, G Bench, H Benner, JA Cappuccio, ... Journal of the American Chemical Society 129 (46), 14348-14354, 2007 | 124 | 2007 |
Kinetics of carboplatin− DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry SS Hah, KM Stivers, RW de Vere White, PT Henderson Chemical research in toxicology 19 (5), 622-626, 2006 | 120 | 2006 |
Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations KE Coldwell, SM Cutts, TJ Ognibene, PT Henderson, DR Phillips Nucleic acids research 36 (16), e100, 2008 | 102 | 2008 |
High-fidelity in vivo replication of DNA base shape mimics without Watson–Crick hydrogen bonds JC Delaney, PT Henderson, SA Helquist, JC Morales, JM Essigmann, ... Proceedings of the National Academy of Sciences 100 (8), 4469-4473, 2003 | 99 | 2003 |
Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range P Sandhu, JS Vogel, MJ Rose, EA Ubick, JE Brunner, MA Wallace, ... Drug metabolism and disposition 32 (11), 1254-1259, 2004 | 93 | 2004 |
Radical cation transport and reaction in RNA/DNA hybrid duplexes: effect of global structure on reactivity V Sartor, PT Henderson, GB Schuster Journal of the American Chemical Society 121 (48), 11027-11033, 1999 | 81 | 1999 |
Human endonuclease III acts preferentially on DNA damage opposite guanine residues in DNA L Eide, L Luna, EC Gustad, PT Henderson, JM Essigmann, B Demple, ... Biochemistry 40 (22), 6653-6659, 2001 | 78 | 2001 |
In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole WL Neeley, JC Delaney, PT Henderson, JM Essigmann Journal of Biological Chemistry 279 (42), 43568-43573, 2004 | 74 | 2004 |
Characterization of oxaliplatin− DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations SS Hah, RA Sumbad, RW de Vere White, KW Turteltaub, PT Henderson Chemical research in toxicology 20 (12), 1745-1751, 2007 | 72 | 2007 |
DNA adducts from anticancer drugs as candidate predictive markers for precision medicine A Stornetta, M Zimmermann, GD Cimino, PT Henderson, SJ Sturla Chemical research in toxicology 30 (1), 388-409, 2017 | 71 | 2017 |
Measurement of 7, 8-dihydro-8-oxo-2′-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry SS Hah, JM Mundt, HM Kim, RA Sumbad, KW Turteltaub, PT Henderson Proceedings of the National Academy of Sciences 104 (27), 11203-11208, 2007 | 63 | 2007 |
Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer GD Cimino, C Pan, PT Henderson Bioanalysis 5 (3), 369-391, 2013 | 59 | 2013 |
Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine MS Cooke, PT Henderson, MD Evans Journal of Clinical Biochemistry and Nutrition 45 (3), 255-270, 2009 | 57 | 2009 |
Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform JA Cappuccio, AK Hinz, EA Kuhn, JE Fletcher, ES Arroyo, PT Henderson, ... High Throughput Protein Expression and Purification: Methods and Protocols …, 2009 | 55 | 2009 |
Urea lesion formation in DNA as a consequence of 7, 8-dihydro-8-oxoguanine oxidation and hydrolysis provides a potent source of point mutations PT Henderson, WL Neeley, JC Delaney, F Gu, JC Niles, SS Hah, ... Chemical research in toxicology 18 (1), 12-18, 2005 | 48 | 2005 |